Beyond the Traffic Light: Rethinking Vendor Performance

From Vendor Oversight to High Performance Governance in Clinical Development

October 22, 2026 | 12 PM ET | 5 PM GMT | 6 PM CET | LinkedIn Live

REGISTER FOR THE WEBINAR

Your KPI turns red. What happens next?

Most clinical organizations already have KPIs, scorecards, governance meetings and traffic light dashboards. But measuring vendor performance is not the same as managing it.

Pharmaceutical companies have made significant progress in vendor oversight, risk management and inspection readiness. The next challenge is turning that visibility into better vendor performance, stronger governance and faster, more informed decisions.

In this Clinical Maestro LinkedIn Live webinar, senior industry leaders will explore how sponsors and CROs can move from monitoring and reporting vendor performance to actively managing it, and how AI can enable a new level of performance intelligence.

From monitoring vendor performance to managing it

A red KPI is useful only if it leads to the right response. The discussion will examine what happens after performance issues become visible and how governance teams can turn measurement into action.

• Are today's KPIs and traffic light dashboards driving better performance, or primarily reporting what has already happened?
• When a KPI turns red, who owns the response, what actions are triggered and when should the issue escalate?
• When a KPI is repeatedly red, how can teams distinguish an isolated issue from a recurring performance trend?
• Are governance meetings driving decisions and resolution, or primarily reviewing information?
• How can organizations move beyond individual vendor scorecards to understand category level and enterprise wide performance and risk?

From data to performance intelligence

Vendor performance information already exists, but it is often fragmented across KPIs, risks, governance minutes, contracts, actions, escalation histories and other documents and systems.

AI creates the opportunity to understand the broader context of a vendor relationship, identify patterns that are difficult to see in dashboards and static documents, and help teams move from asking what happened to understanding why it is happening, what it means and what should happen next.

• Identify trends, recurring issues and performance patterns across fragmented information.
• Analyze performance across vendors within a category and across common themes spanning multiple categories.
• Connect KPI, risk, governance, contract, action and escalation information.
• Turn live performance data into decision ready insights for governance teams.

See the next evolution of VISION

The discussion will be followed by an approximately 25 minute live demonstration of the upcoming VISION release.

The demonstration will show how KPIs, trends, risks, governance information, contracts, actions and escalation history can be connected through AI powered Insight Reports, helping teams spend less time assembling information and more time making decisions.

The question we want to answer

Are your vendors performing, and does your governance model actually improve performance?

Who should attend?

This webinar is designed for professionals who own, influence or operationalize vendor performance and governance in clinical development, particularly within pharmaceutical and biotechnology organizations.

• Clinical Outsourcing and Strategic Sourcing leaders
• Clinical Operations and Global Clinical Operations leaders
• Vendor Management and Vendor Governance leaders
• Clinical Business Operations and R&D Business Operations leaders
• R&D Sourcing and Clinical Procurement leaders
• Clinical Quality, GCP Quality and Vendor Quality stakeholders

Speakers

Anca Copaescu
CEO, Clinical Maestro

Bruno Gagnon
Senior Vice President, Global Clinical Operations, Spruce Biosciences

Andrei Antonescu
Head of Product, Clinical Maestro

REGISTER FOR THE WEBINAR

LinkedIn registration: https://www.linkedin.com/events/7512835855695380480?viewAsMember=true

FAQ

What is clinical vendor performance management?

Clinical vendor performance management is the process of using KPIs, trends, risks, governance information, actions and escalation data to actively manage and improve the performance of CROs and other clinical vendors, rather than only reporting historical results.

What should happen when a clinical vendor KPI turns red?

A red KPI should trigger a defined response with clear ownership, appropriate actions and escalation when required. The goal is to move from identifying a performance issue to understanding its cause, determining whether it is isolated or recurring, and driving resolution.

How can sponsors improve vendor governance?

Sponsors can strengthen vendor governance by connecting performance measurement with accountability, action, escalation and decision making. Governance meetings should help resolve issues and improve performance, not simply review information.

How can AI support clinical vendor performance management?

AI can connect fragmented vendor information across KPIs, risks, governance records, contracts, actions and escalation histories. This can help teams identify trends and recurring issues, understand broader performance context and generate decision ready performance insights.

What will the VISION demonstration show?

The live demonstration will show the upcoming VISION release and how KPIs, trends, risks, governance information, contracts, actions and escalation history can be connected through AI powered Insight Reports.

Who should attend this webinar?

The webinar is relevant to leaders and stakeholders in Clinical Outsourcing, Clinical Operations, Vendor Management and Governance, Clinical Business Operations, R&D Sourcing, Clinical Procurement and Clinical Quality, particularly within pharma and biotech organizations.